Febrile Neutropenia
Information
- Disease name
- Febrile Neutropenia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02856204 | Completed | Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia | August 2016 | April 2019 | |
| NCT00137787 | Completed | Phase 3 | Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases | April 2005 | May 2010 |
| NCT00035425 | Completed | Phase 3 | Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection | November 2001 | November 2002 |
| NCT00454272 | Completed | Phase 4 | Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients | January 2005 | August 2007 |
| NCT00462878 | Completed | Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation | November 2002 | April 2009 | |
| NCT00503854 | Completed | Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia | May 31, 2007 | April 5, 2018 | |
| NCT00536081 | Completed | Phase 3 | Various G-CSF Regimens to Prevent Infection During Chemotherapy | January 2008 | December 1, 2016 |
| NCT00709358 | Completed | Phase 4 | Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections | May 2008 | September 2010 |
| NCT00723073 | Completed | Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia | January 2008 | May 2008 | |
| NCT00928291 | Completed | N/A | Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia | January 2010 | April 2011 |
| NCT00945555 | Completed | Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options | June 2009 | October 2010 | |
| NCT01114165 | Completed | Phase 4 | Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients | May 2010 | September 2012 |
| NCT04914702 | Completed | Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer. | September 16, 2021 | March 1, 2022 | |
| NCT01344681 | Completed | Phase 2 | Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases | June 2011 | March 2014 |
| NCT01401010 | Completed | Phase 4 | Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients | August 2010 | February 2012 |
| NCT04910698 | Completed | Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia | January 1, 2020 | June 1, 2020 | |
| NCT01459653 | Completed | Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor | March 2010 | August 2013 | |
| NCT04134429 | Completed | Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy | November 29, 2019 | January 13, 2020 | |
| NCT01581333 | Completed | Phase 4 | Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia | April 2012 | June 2016 |
| NCT01611051 | Completed | Phase 3 | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy | March 2012 | |
| NCT03968328 | Completed | Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients | June 19, 2015 | January 17, 2023 | |
| NCT02005783 | Completed | Phase 2 | Study of Danggui Buxue Decoction in Preventing Neutropenia | October 2013 | October 2015 |
| NCT02119715 | Completed | Phase 2 | A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy | February 2011 | December 2012 |
| NCT02149329 | Completed | Phase 4 | Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO | December 2014 | August 5, 2019 |
| NCT03641131 | Completed | Ampholipad Real-World Data in Taiwan | September 9, 2018 | January 8, 2019 | |
| NCT03619252 | Completed | Phase 4 | Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents | July 1, 2018 | June 30, 2021 |
| NCT03429387 | Completed | N/A | PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia | January 8, 2018 | January 23, 2021 |
| NCT03104595 | Completed | Phase 1/Phase 2 | Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer | October 30, 2017 | December 5, 2019 |
| NCT03087227 | Completed | N/A | Shared Health Information System for Febrile Neutropenia | February 22, 2017 | October 20, 2019 |
| NCT02702583 | Completed | The Oral Cavity as a Source of Febrile Neutropenia | December 2015 | January 2021 | |
| NCT02728596 | Completed | N/A | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) | October 7, 2016 | August 12, 2021 |
| NCT02906254 | Completed | Early Antibiotic Discontinuation in FUO | February 2014 | September 2015 | |
| NCT06450821 | Not yet recruiting | N/A | PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications | July 2024 | October 2026 |
| NCT05576220 | Not yet recruiting | N/A | Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy | April 30, 2023 | July 30, 2023 |
| NCT05665478 | Not yet recruiting | N/A | Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients | December 31, 2022 | December 31, 2025 |
| NCT05786495 | Not yet recruiting | N/A | Short Antibiotic Treatment in High Risk Febrile Neutropenia | May 1, 2023 | January 31, 2026 |
| NCT05815628 | Not yet recruiting | Next-Generation-Sequencing Approach to Neutropenic Sepsis | June 1, 2024 | July 1, 2025 | |
| NCT06116734 | Not yet recruiting | Phase 3 | Lapelga vs Gastrofil | November 1, 2023 | November 1, 2025 |
| NCT06278896 | Not yet recruiting | Phase 3 | Early Neutropenic Fever De-escalation of Antibiotics Study | March 1, 2024 | March 1, 2028 |
| NCT06293677 | Not yet recruiting | Phase 4 | Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance | March 1, 2024 | March 2026 |
| NCT06342115 | Not yet recruiting | Phase 4 | Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens | June 2024 | April 2025 |
| NCT02536599 | Recruiting | Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia | October 2015 | November 2023 | |
| NCT05174546 | Recruiting | New Diagnostics in Neutropenia | January 10, 2023 | July 2023 | |
| NCT05311254 | Recruiting | Phase 3 | A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia | March 14, 2022 | March 14, 2024 |
| NCT05784844 | Recruiting | Phase 4 | Antimicrobial Revision in Persistent Febrile Neutropenia | August 2024 | April 2025 |
| NCT05584930 | Recruiting | N/A | Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN) | October 10, 2022 | March 2025 |
| NCT03078010 | Recruiting | Phase 2 | Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant | February 10, 2017 | February 2025 |
| NCT04948463 | Recruiting | Phase 4 | Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia | November 15, 2021 | August 2026 |
| NCT03342365 | Terminated | Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology | April 13, 2018 | December 29, 2018 | |
| NCT01216241 | Terminated | Phase 3 | Daptomycin Versus Placebo in Patients With Neutropenia and Fever | April 2011 | April 2013 |
| NCT02732327 | Terminated | Phase 2 | Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer | May 17, 2016 | June 27, 2016 |
| NCT02685111 | Terminated | Phase 2 | Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) | February 2016 | December 2017 |
| NCT00421187 | Terminated | Phase 4 | Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics | March 2007 | May 2008 |
| NCT05206006 | Unknown status | N/A | Impact of Computerized Decision Support for ANTIBIOtic Prescription in Cancer Patients With Febrile NEutropenia in the Emergency Department on Treatment Failure. | February 14, 2022 | June 21, 2023 |
| NCT02806557 | Unknown status | Profiling Neutrophil Counts in Patients on Chemotherapy | September 2016 | March 2018 | |
| NCT02544685 | Unknown status | Phase 2 | Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients | July 2010 | October 2019 |
| NCT05149547 | Unknown status | mNGS Versus Blood Culture in FN | October 15, 2021 | August 31, 2022 | |
| NCT03618810 | Unknown status | Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer | January 20, 2019 | December 31, 2021 | |
| NCT02463747 | Unknown status | Phase 4 | Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia | June 2015 | July 2017 |
| NCT02364466 | Unknown status | Cohort of Peripheral T Cell Lymphoma | January 2015 | December 2019 | |
| NCT03740464 | Unknown status | Phase 3 | Long-acting G-CSF for Febrile Neutropenia | November 10, 2018 | November 10, 2023 |
| NCT03793205 | Unknown status | Phase 4 | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients | January 3, 2019 | January 1, 2020 |
| NCT01684189 | Unknown status | Registry of Febrile Neutropenia and Invasive Fungal Infections | November 2011 | August 2013 | |
| NCT01560195 | Unknown status | Phase 3 | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy | April 2012 | |
| NCT04233996 | Unknown status | Phase 4 | Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients | June 5, 2019 | December 31, 2022 |
| NCT04662892 | Unknown status | An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca | August 1, 2020 | December 15, 2022 | |
| NCT04758442 | Unknown status | N/A | Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology | February 1, 2021 | October 31, 2021 |
| NCT03449693 | Unknown status | Phase 2 | Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia | October 19, 2017 | December 2019 |
| NCT03364257 | Unknown status | iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients | May 18, 2018 | May 31, 2019 | |
| NCT04698057 | Withdrawn | Phase 3 | Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. | March 1, 2022 | June 1, 2025 |
| NCT01450241 | Withdrawn | N/A | Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia | January 2012 | January 2015 |
- MedGen concept unique identifier (MedGen Concept name)
- C0746883
- MedGen unique identifier (MedGen Concept name)
- 152883
- MeSH unique ID (MeSH (Medical Subject Headings))
- D064147